CSRnD

Zurich, Switzerland Founded: 1995 • Age: 31 yrs
AI-driven tools for accelerating drug discovery processes.

About CSRnD

CSRnD is a Technology company based in Zurich (Switzerland) founded in 1995. It operates as an AI-driven tools for accelerating drug discovery processes. It operates on a B2B and SaaS model. CSRnD offers products and services including DOLOS AI LEAD OPTIMIZER, DOLOS AI Chemist, and DOLOS AI GENE PREDICTOR. Its focus areas include Life Sciences, Computational Biology, AI Tools and Gene Prediction. Its legal entity is Chemical Science Research & Development. Its competitors include Archon Bio, Etcembly, SQALE, Neuromathix and Sprectroo and 2 more; 2 of its 7 listed competitors have raised funding.

Company details

CSRD provides AI-based solutions for drug development, including lead optimization and gene prediction tools. They analyze millions of molecules to identify promising candidates, improving accuracy and speed over traditional methods. Operating from Zurich, Switzerland, and Cambridge, USA, CSRD serves pharmaceutical clients by enhancing pre-clinical success rates and reducing costs through innovative algorithms.

  • Headquarters Zurich, Switzerland
  • Sectors
    Technology
  • Website csrnd.com
  • Legal Name Chemical Science Research & Development

Products & Services of CSRnD

CSRnD offers a comprehensive portfolio of products and services, including DOLOS AI LEAD OPTIMIZER, DOLOS AI Chemist, and DOLOS AI GENE PREDICTOR.

DOLOS AI LEAD OPTIMIZER
Drug Optimization

Identifies novel steps to improve drug candidate success rates.

DOLOS AI Chemist
Drug Discovery

Analyzes molecules to select promising drug candidates efficiently.

DOLOS AI GENE PREDICTOR
Gene Prediction

Predicts DNA behavior using deep learning for viable cures.

Competitors of CSRnD

CSRnD has 7 listed competitors in our database, 2 of them funded. They include Archon Bio, Etcembly, SQALE, Neuromathix and Sprectroo, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
archon.bio2023Seattle, United States$20M–
Provider of computational platform to develop protein therapeutics
etcembly.io2020Harwell, United Kingdom$12.66M–
Provider of AI-based platform to engineer novel T cell receptors for cancer immunotherapy
sqale.ai2023Copenhagen, Denmark––
Provides bioprocess optimization services for microalgae and precision fermentation companies.
neuromathix.com2001Brisbane, Australia––
Offers decision support software for personalized healthcare models based on patient data.
sprectroo.com2022Santa Clara, United States––
Sprectroo is an AI-driven platform for drug derivatization and repurposing.
protains.com2024–––
AI-driven platform for drug discovery using algorithms and computing resources.
elenaetherapeutics.com2021Berkeley, United States––
Researches and develops innovative cures for various diseases using expert methods.
Premium access

Detailed competitors of CSRnD

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in AI in Life Sciences

10 companies that operate in the same segment as CSRnD (AI in Life Sciences), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provides AI solutions and services for research publishing and communication.
2001Mumbai, Maharashtra, India–USD 91.43 M1,025
High-performance computing research is conducted by BSC in Barcelona.
2005Barcelona, Catalonia, Spain–––
Scientific communications, localization, and AI services for researchers and publishers.
2000Mumbai, Maharashtra, India–USD 25.46 M243
Fullpower-AI is recognized as a leading AI-biosensing platform company.
2003Santa Cruz, California, United StatesUSD 25 M––
Drug candidates are optimized via machine learning-enhanced medicinal chemistry.
2020Durham, North Carolina, United StatesUSD 5.5 M––
Provides big data analytics solutions tailored for the life sciences sector.
2006Bengaluru, Karnataka, India–––
AI-powered drug intelligence platform for life science professionals
–Beijing, China–––
Resource and marketplace for lab tools, services, and research news.
2013Bengaluru, Karnataka, India–––
Live cell imaging solutions are delivered via an AI-based platform.
–Wilmington, Delaware, United States–––
PR agency offering AI-assisted communications and media services for biotech companies.
2023Singapore, Singapore–––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about CSRnD

CSRnD was founded in 1995.

CSRnD is headquartered in Zurich, Switzerland.

CSRD provides AI-based solutions for drug development, including lead optimization and gene prediction tools. They analyze millions of molecules to identify promising candidates, improving accuracy and speed over traditional methods. Operating from Zurich, Switzerland, and Cambridge, USA, CSRD serves pharmaceutical clients by enhancing pre-clinical success rates and reducing costs through innovative algorithms.

CSRnD's top competitors include Etcembly, Archon Bio and SQALE.

CSRnD offers DOLOS AI LEAD OPTIMIZER, DOLOS AI Chemist, and DOLOS AI GENE PREDICTOR.

CSRnD operates through Chemical Science Research & Development.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available